Search

Compugen Ltd

Uždarymo kaina

2.34 -0.85

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.2800000000000002

Max

2.42

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-65M

-7.7M

Pardavimai

-65M

2.2M

P/E

Sektoriaus vid.

6.29

60.149

Pelnas, tenkantis vienai akcijai

-0.08

Pelno marža

-352.436

Darbuotojai

75

EBITDA

-64M

-7.7M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+97.88% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-44M

226M

Ankstesnė atidarymo kaina

3.19

Ankstesnė uždarymo kaina

2.34

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-15 23:56; UTC

NXP Semiconductors NV shares are higher in after-market hours, though no specific news was identified. Broader market trends include a decline in the producer price index.

2026-07-15 23:56; UTC

abrdn Physical Palladium Shares ETF trades lower in after-market hours, despite broader market gains in U.S. technology stocks contributing to positive sentiment.

2026-07-15 23:56; UTC

ETF Constituents
Macro News
Correlated Moves

iShares Biotechnology ETF advances in after-market trading, supported by gains in Gilead Sciences and Moderna amid positive inflation data and producer price declines.

2026-07-15 23:56; UTC

Correlated Moves

Texas Instruments shares declined in after-market trading, aligning with a slight decrease in the Nasdaq 100 Index amid easing inflationary pressures.

2026-07-15 23:52; UTC

Correlated Moves
Social Media
News

Western Digital shares fell after hours, closing at about $513.97. Option traders showed bearish sentiment, with puts outpacing calls in volume.

2026-07-15 23:52; UTC

Global equity markets rise, led by Asia's Hang Seng Index, while U.S. stocks remain flat amid easing inflation signals and geopolitical tensions affecting oil prices.

2026-07-15 23:52; UTC

European equity markets show mixed performance amid rising geopolitical tensions and disappointing Eurozone industrial production, while U.S. futures rise on better-than-expected producer price data.

2026-07-15 23:52; UTC

U.S. equity indices remain flat as investors weigh mixed economic data, geopolitical tensions, and upcoming retail sales figures.

2026-07-15 23:52; UTC

Asia equity markets rise on softer U.S. inflation data, easing Fed rate hike concerns, while geopolitical tensions and strong performances from tech giants like Apple and Microsoft shape market dynamics.

2026-07-15 23:52; UTC

Pending Home Sales Expected to Decline 0.5% in June 2026 Amid Mixed Market Sentiment and Affordability Concerns

2026-07-15 23:52; UTC

Pending Home Sales Data Release on July 16, 2026, Signals Optimism Amidst Supply Constraints and Rising Prices.

2026-07-15 23:52; UTC

US Business Inventories MoM data for May 2026 expected to rise by 0.3% amid economic uncertainties and geopolitical tensions impacting market dynamics.

2026-07-15 23:52; UTC

NAHB Housing Market Index Set for July 16 Release Amid Improved Builder Confidence and Stabilizing Home Sales, Despite Geopolitical Risks.

2026-07-15 23:52; UTC

Correlated Moves

USD/SEK is lower as the Producer Price Index showed a larger-than-expected decline. The session has seen notable volatility since Tuesday's close.

2026-07-15 23:51; UTC

ETF Constituents

iShares China Large-Cap ETF showed little change in after-market trading. Top contributors included LI and JD, both recording modest returns.

2026-07-15 23:46; UTC

Monster Beverage Corp shares are higher in after-market hours. The stock remains above its 20-day moving average and near the upper end of its trading range.

2026-07-15 23:46; UTC

Correlated Moves

JD.Com Inc. shares are roughly flat in after-market trading, reflecting stability amid easing inflation fears and a slight rise in Alibaba Group.

2026-07-15 23:46; UTC

Lululemon Athletica shares are higher in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month trading range.

2026-07-15 23:42; UTC

Mortgage Rates Hit Nine-Month High at 6.65%, Sparking Concerns Over Housing Affordability and Consumer Demand Amid Economic Uncertainty.

2026-07-15 23:42; UTC

Canada's Core Inflation Rate Release on July 20, 2026, Expected to Impact Monetary Policy Amid Geopolitical Tensions and Rising Oil Prices.

2026-07-15 23:42; UTC

Canada's upcoming inflation report on July 20, 2026, is poised to reflect market concerns over geopolitical tensions and their impact on economic sentiment amid recent U.S. consumer inflation declines.

2026-07-15 23:42; UTC

Canada's Inflation Rate Data Set for Release on July 20, Amid Mixed Market Sentiment Following U.S. CPI Decline

2026-07-15 23:41; UTC

NetApp Inc. shares are lower in after-market trading, retracing from an initial peak. Broader market caution, influenced by geopolitical tensions, may be a factor.

2026-07-15 23:41; UTC

Macro News
ETF Constituents

The Vanguard Information Technology ETF is lower in after-market hours, reflecting a slight decline amid generally positive sector sentiment and negative returns from key holdings.

2026-07-15 23:41; UTC

Macro News
ETF Constituents

Utilities Select Sector SPDR Fund rises in after-market trading, supported by easing inflation concerns and modest gains from Southern Company and American Electric Power.

2026-07-15 23:41; UTC

Macro News

Bitcoin's price is lower during Wednesday's session, despite recent positive inflation data. Geopolitical tensions may be causing caution among investors in traditional markets.

2026-07-15 23:41; UTC

ETF Constituents
Correlated Moves

Vanguard Value ETF closed lower in after-market trading, influenced by declines in top holdings like UnitedHealth Group and Bank of America.

2026-07-15 23:41; UTC

Fiserv Inc shares are higher in after-market trading, maintaining a strong upward trajectory since Wednesday's close and nearing the upper end of its one-month range.

2026-07-15 23:36; UTC

T-Mobile US Inc shares are trading higher in after-market hours, recovering from an earlier dip and positioned above its 20-day moving average.

2026-07-15 23:36; UTC

Biogen Inc. shares declined in after-market trading, reflecting ongoing weakness amid broader market caution related to geopolitical tensions involving the U.S. and Iran.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

97.88% į viršų

12 mėnesių prognozė

Vidutinis 4.67 USD  97.88%

Aukščiausias 5 USD

Žemiausias 4 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat